Biome Australia (ASX:BIO) Common Stock: A$23.45 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASX:BIO Biome Australia Ltd ASX:BIO
33 GF Score
Price A$0.25
GF Value A$0.66
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Biome Australia Common Stock?

Biome Australia ASX:BIO -2.88% 33 Common Stock is A$23.45 Mil as of Dec. 2025. GuruFocus rates ASX:BIO with a GF Score™ of 33/100 and a GF Value™ of A$0.66 (Possible Value Trap). The stock has 5 warning signs investors should review.

Biome Australia's quarterly common stock increased from Dec. 2024 (A$23.05 Mil) to Jun. 2025 (A$23.32 Mil) and increased from Jun. 2025 (A$23.32 Mil) to Dec. 2025 (A$23.45 Mil).

Biome Australia's annual common stock increased from Jun. 2023 (A$20.76 Mil) to Jun. 2024 (A$21.73 Mil) and increased from Jun. 2024 (A$21.73 Mil) to Jun. 2025 (A$23.32 Mil).

Biome Australia Common Stock Historical Data

* Premium members only.

The historical data trend for Biome Australia's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biome Australia Common Stock Chart

Biome Australia Annual Data
Trend Jun21 Jun22 Jun23 Jun24 Jun25
Common Stock
20.80 20.64 20.76 21.73 23.32

Biome Australia Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only 20.84 21.73 23.05 23.32 23.45
ASX:BIO
33GF Score
Biome Australia Ltd ASX:BIO
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Biome Australia Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of A$23.45 Mil mean?
Biome Australia (ASX:BIO) has a Common Stock of A$23.45 Mil as of Dec. 2025. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Biome Australia and its competitors.
Is Biome Australia's Common Stock too high?
Biome Australia's current Common Stock is A$23.45 Mil. Overall, Biome Australia has a GF Score™ of 33/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Biome Australia's Common Stock compare to KHC and GIS?
Biome Australia's Common Stock of A$23.45 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Consumer Packaged Goods company?
A good Common Stock depends on the Consumer Packaged Goods industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Biome Australia and its competitors. Biome Australia's current Common Stock is A$23.45 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biome Australia stock overvalued right now?
Based on GuruFocus' analysis, Biome Australia (ASX:BIO) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.66, compared to a current price of A$0.25 — trading 61.7% below its estimated fair value. The current Common Stock is A$23.45 Mil. Biome Australia's overall GF Score™ is 33/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Biome Australia (ASX:BIO), the current Common Stock is A$23.45 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Biome Australia (ASX:BIO) Overvalued in 2026?

Based on GuruFocus' analysis, Biome Australia stock appears to be undervalued. The current stock price of A$0.25 is trading 61.7% below its estimated GF Value™ of A$0.66. GuruFocus considers Biome Australia to be Possible Value Trap.

Key valuation signals for ASX:BIO:

  • Common Stock: A$23.45 Mil
  • GF Value™: A$0.66 vs. price of A$0.25 (61.7% below fair value)
  • GF Score™: 33/100 with 5 warning signs

No single metric tells the full story. See the ASX:BIO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Biome Australia Business Description

Address 192-194 Johnston Street, Collingwood, VIC, AUS, 3066
Biome Australia Ltd licences, develops, and markets evidence-based, complementary medicines, including nutraceuticals vitamins and weight management products and live biotherapeutics. The company has one operating segment: researching, developing, manufacturing and distributing evidence-based products linking the gut and human health. Domestically it caters to Australia and In international markets, the Group distributes and markets its Activated Probiotics range in the United Kingdom and New Zealand through independent health practitioners.
33GF Score

Get the complete analysis for ASX:BIO

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.25
Price
A$0.66
GF Value